跳至主要内容
临床试验/NCT06594718
NCT06594718尚未招募不适用

Endoscopic Treatment of Zenker's Diverticulum: a Prospective Observational Study Comparing Tunnelization (Z-POEM) Versus Non-Tunnelization Techniques

Société Française d'Endoscopie Digestive0 个研究点目标入组 128 人开始时间: 2024年10月31日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
128
主要终点
Symptomatic recurrence rate after endoscopic tunnelization therapy (Z-POEM) compared to non-tunnelization techniques in patients with symptomatic Zenker's diverticulum.

研究概览

简要总结

Prospective comparative observational study in numerous reference centers in France, comparing Tunnelization (Z-POEM) versus Non-Tunnelization Techniques according to the usual practices. This is a prospective, comparative, observational, multicenter study with the primary objective of comparing the symptomatic recurrence rate one year after endoscopic tunnelization therapy (Z-POEM) versus non-tunnelization techniques in patients with symptomatic Zenker's diverticulum.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with symptomatic Zenker's diverticulum (Augsburg score ≥5 )
  • Diagnostic evaluation including esophagogastroduodenoscopy (EGD) and a barium swallow (TOGD) with measurement of the diverticulum's height.
  • Patient aged 18 years or older
  • Patient with ASA 1, ASA 2, ASA 3 status
  • No participation in another concurrent clinical study

排除标准

  • Patient under 18 years old
  • Patient with ASA 4 or ASA 5 status
  • Pregnant woman
  • Patient with coagulation disorders preventing the performance a polypectomy: PT < 50%, Platelets < 50,000/mm³, ongoing effective anticoagulation, or current clopidogrel use.
  • Patient who has already undergone initial endoscopic or surgical treatment for Zenker's diverticulum

结局指标

主要结局

Symptomatic recurrence rate after endoscopic tunnelization therapy (Z-POEM) compared to non-tunnelization techniques in patients with symptomatic Zenker's diverticulum.

时间窗: 12 months

Symptomatic recurrence is defined by: Clinical resolution after endoscopic treatment, as assessed clinically at 3 months, with an Augsburg score \<5. Reappearance of clinical symptoms, following clinical resolution after endoscopic treatment, with an Augsburg score ≥5.

次要结局

  • Complication rate associated with the endoscopic procedure(15 days)
  • Clinical success rate after endoscopic treatment.(3 months)
  • Variation in Augsburg score at different time points(3 months, 6 months, 12 months, and 24 months)
  • Radiographic resolution rate of the diverticulum(3 months)
  • Symptomatic Recurrence Rate Post-Treatment:(at 3, 6, 12, and 24 Months)

研究者

发起方
Société Française d'Endoscopie Digestive
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bertrand Brieau

Medical doctor, Principal Investigator

Société Française d'Endoscopie Digestive

相似试验